Protocol design and synopsis: Omalizumab as Monotherapy and as Adjunct Therapy to Multiallergen OIT in Children and Adults with Food Allergy (OUtMATCH)

BACKGROUND: Food allergy is common and causes substantial morbidity and even mortality. Safe and effective treatments for food allergy would therefore be highly desirable, especially for individuals with multiple food allergies. OBJECTIVES: Our aim was to describe a phase 3 study on treatment of pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Wood, Robert A., Chinthrajah, R. Sharon, Rudman Spergel, Amanda K., Babineau, Denise C., Sicherer, Scott H., Kim, Edwin H., Shreffler, Wayne G., Jones, Stacie M., Leung, Donald Y.M., Vickery, Brian P., Bird, J. Andrew, Spergel, Jonathan M., Kulis, Michael, Iqbal, Ahmar, Kaufman, Derrick, Umetsu, Dale T., Ligueros-Saylan, Monica, Uddin, Alkaz, Fogel, Robert B., Lussier, Stephanie, Mudd, Kim, Poyser, Julian, MacPhee, Martin, Veri, Maria, Davidson, Wendy, Hamrah, Sanaz, Long, Andrew, Togias, Alkis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509974/
https://www.ncbi.nlm.nih.gov/pubmed/37779534
http://dx.doi.org/10.1016/j.jacig.2022.05.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10509974/
https://www.ncbi.nlm.nih.gov/pubmed/37779534
http://dx.doi.org/10.1016/j.jacig.2022.05.006

Ejemplares similares